Stevastelin B

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameStevastelin B
Drug Alias NameNK-37486B
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsRejection of organ transplantation +[2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNippon Kayaku Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNippon Kayaku Co Ltd
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantation +[2

Other Information

ATC CodeN/A
Related LinksN/A